A chemo-enzymatic synthesis of [(5-acetamido-9-O-acetyl-3,5-
Introduction
Sialic acids are a family of approximately 50 naturally occurring 2-keto-3-deoxy-nononic acids that are involved in a wide range of biological processes. [1] [2] [3] The C-5-amino derivative represents the long-known neuraminic acid and its amino function can either be acetylated (Neu5Ac) or glycolylated (Neu5Gc). As terminal components of glycoproteins and glycolipids, neuraminic acids are a-(2?3)-or a-(2?6)-linked to galactosides or a-(2?6)-linked to 2-acetamido-galactosides. [4] [5] [6] Enzymatic acetylation, lactylation, sulfation, methylation and phosphorylation of free hydroxyls give a large structural diversity of sialic acids. 3, 7 O-Acetylation of sialic acids takes place in the Golgi apparatus by membrane bound O-acetyltransferases. Interestingly, different cell types show different substrate selectivity for acetylation of sialic acid indicating that there are different classes of acetyltransfereases. 2, 3, 8 Alternatively, it may be possible that adaptor proteins control the sub-strate specificity. Initially, acetyl transferases introduce an acetyl ester at C-7 or C-9 of sialic acid and under physiological conditions, the C-7 acetyl ester can migrate to C-8 or C-9 making C-9 acetylation (Neu5,9Ac 2 ) the most prevalent sialic acid modification of cell surface glycoconjugates. 2, 7 Acetylation of the C-4 hydroxyl of sialosides has also been observed. 9 It has been shown that 9-O-acetylation of sialic acids can dramatically influence biological properties of glycoconjugates. 2, 7, 10 For example, O-acetylation of sialosides on the surface of thymocytes results in loss of binding to Siglec-2 (CD22b) on B-cells. 11 Abrogation of 9-O-acetylated deleteriously affects development of transgenic mice. This modification is also involved in cell specific recognition by influenza C and corona viruses. 12, 13 It has also been demonstrated that sialoglycoproteins having 9-O-acetylation are expressed on lymphoblasts of children with acute lymphoblastic leukemia. 14 Glycoproteins and gangliosides from rat, mouse and chicken erythrocytes express Neu5,9Ac 2 -a-(2?3)-Galb-(1?3)-GalNAc, which serves as targets for the binding of naturally occurring antibodies. 12, 15, 16 In microorganisms, such as the trypanosoma parasite Crithidia fasciculata and the pathogenic fungus Cryptococcus neoformans, Neu5,9Ac 2 can be glycosidically linked to Gal-b-(1?3)-GalNAc. 17, 18 The potential impact of 9-O-acetylation of the GD 1a ganglioside on the overall conformation and recognition by a natural human antibody has been investigated by molecular dynamics simulations and NMR. It was found that acetylation did not affect the conformational properties of the oligosaccharide. However, it was shown that an antibody specific for a 9-O-acetylated ganglioside can make direct interactions with the acetyl group rationalizing the selective recognition of acetylated derivatives. 16, 19 As part of a program to develop monoclonal antibodies against sialo-oligosaccharides bearing 9-O-acetyl esters, we report here an efficient chemo-enzymatic synthesis of Neu5,9Ac 2 -a-(2?3)-Gal-b-(1?3)-Gal-NAc-O-Ser (1) . It is to be expected that this compound can be employed for the preparation of fully synthetic immunogens for the development of monoclonal antibodies. [20] [21] [22] 
Results and discussion
While relatively efficient methods have been developed for the introduction of sialosides, the preparation of acetylated analogues is less well developed. It was anticipated that compound 1 could be prepared by a regioselective chemical acetylation 23 of Neu5Ac (2) to give 9-O-acetylated sialic acid 3, which can then be enzymatically converted into CMP-Neu5,9Ac 2 (4) employing the recombinant CMP-sialic acid synthetase from Neisseria meningitis. This enzyme possesses a flexible substrate specificity and has been employed for the synthesis of CMP-sialic acid analogues such as CMP-Neu5,9Ac 2 . 24, 25, 30 The resulting compound can then be used for the enzymatic glycosylation 26 of the C-3 0 hydroxyl of chemically prepared glycopeptide 10 using the recombinant rat a-(2?3)-sialyltransferase [EC 2.4.99.4] expressed in Spodooptera frugiperda to give, after removal of the N a -CBz protecting group of serine, target compound 1.
Sialyltransferases exhibit some flexibility with regard to the structure of their acceptors and are able to trans-fer modified sialic acids from corresponding CMP-derivatives. 24, 25, 27 For example, a rat liver a-(2?3)sialyltransferase has been used to transfer Neu5,9Ac 2 from the corresponding CMP-donor to various glycoproteins, 28 and a porcine liver a(2?6)-sialyltransferase has been employed for the chemo-enzymatic synthesis of Neu5,9Ac 2 -a-(2?6)-Gal-b-(1?4)-GlcNAc-a-OCH 3 . 24 Recently, a library of (2?6)-linked modified sialosides of Gal-b-(1?4)-GlcNAc-a-O-(CH 2 ) 3 N 3 , which includes four 9-O-acetylated sialoside derivatives, has been prepared using the flexible recombinant Photobacterium damsela [EC 2.4.99.1] a-(2?6)-sialyltransferase by a one-pot three-enzyme system. 29 The enzymatic synthesis of the Neu5,9Ac 2 -a-(2?3)-Gal-O-p-nitrophenyl glycoside has also been reported. 30 It was anticipated that C-9 derivatives of sialic acid (Neu5Ac) would be readily available from Neu5Ac by a chemical regioselective acetylation. 23 (4) . The reported purification strategy 25 gave a compound 4 contaminated with phosphorylated nucleotides (CTP, CDP and CMP) and a small amount of CMP-Neu5Ac and Neu5Ac. However, it was found that highly pure 4 could be obtained by removal of inorganic salts by selective precipitation 31 in an ethanol-H 2 O mixture (9:1, v:v, twice) followed by size exclusion chromatography over extra fine Biogel P-2 using ammonium bicarbonate buffer as eluent at 4°C.
Glycosylation of thioglycoside 5 32 with properly protected serine derivative 6 26 (Scheme 2). Treatment of 7 with aqueous acetic acid removed the benzylidene acetal and acetylation of the resulting free hydroxyls gave compound 8 in excellent overall yield. Next, the azido moiety of 8 was converted into an acetamido derivative by reaction with thioacetic acid in pyridine [33] [34] [35] and the resulting compound 9 was treated with a mixture of TFA and water to remove the t-butyl ester, and then with NaOMe in methanol to cleave the acetyl esters to give glycopeptide 10. 36 At this stage of the synthesis, the Cbz group was kept intact because protection of the amino group of serine is required for glycopeptide synthesis.
Next, attention was focused on the enzymatic sialylation of 10 using a CMP-Neu5,9Ac 2 donor (4) (Scheme 3). Thus, the recombinant rat a-(2?3)-sialyltransferase [EC 2.4.99.4] expressed in S. frugiperda and a calf intestine alkaline phosphatase [EC 3.6.1.1] were added to a mixture of 4 and 10 dissolved in cacodylate buffer (50 mM; pH 6.2) containing Triton X-100 and BSA. 37 After incubation at 37°C for 2 h, another portion of alkaline phosphatase and CMP-Neu5,9Ac 2 (4) was added and after occasional stirring for an additional 3.5 h, TLC analysis showed complete consumption of the starting material 4 and the formation of a new product. Purification of the crude reaction mixture by a reverse-phase C 18 column chromatography followed by an ion exchange chromatography using Biorad AG 50W-X8 (100-200 mesh, Na + form) at 4°C, gave a pure trisaccharide 11 in a yield of 69%. In addition, a small amount (<5%) of 9-O-deacetylated product was also isolated.
Compound 11 is appropriately protected for glycopeptide synthesis. However, fully unprotected 1 could be obtained by catalytic hydrogenation over Pd-C to remove the N a -Cbz group followed by purification by a Biogel P-2 size exclusion column chromatography. The chemical shift of the C-9 protons clearly demonstrated the presence of the C-9 acetyl ester: 4.37 (dd, 1H, J 8 00 ;9 00 a ¼ 2:2 Hz, J 9 00 a;9 00 b ¼ 12:0 Hz, H-9 00 a) and 4.19 (dd, 1H, J 8 00 ;9 00 b ¼ 5:8 Hz, J 9 00 a;9 00 b ¼ 12:0 Hz, H-9 00 b).
In conclusion, we have developed an efficient chemoenzymatic synthesis of the trisaccharide 11, which is appropriately protected for glycopeptide synthesis. It has been shown that the rat recombinant a-(2?3)-sialyltransferase expressed in S. frugiperda can accept CMP-Neu5,9Ac 2 as a donor. The improved purification protocol for CMP-Neu5,9Ac 2 was essential for the successful transfer of CMP-Neu5,9Ac 2 to glycosyl acceptor Gal-b- 
Ph 2 SO (83 mg, 0.411 mmol), di-t-butyl-3-methyl pyridine (90.4 mg, 0.441 mmol) and crushed activated molecular sieves 4 Å (500 mg) were added to a cooled solution (À70°C) of disaccharide 5, (120 mg, 0.147 mmol) in CH 2 Cl 2 (6 mL) prior to the addition of trifluoromethanesulfonic anhydride (58 mg, 36 lL, 0.205 mmol). After stirring the mixture at À70°C for 5 min, a solution of 6 (85.5 mg, 0.29 mmol) in CH 2 Cl 2 (0.5 mL) was added dropwise by syringe. The resulting reaction mixture was stirred at À60°C for 1 h and then allowed to warmed to room temperature over a period of 3 h. TLC analysis (hexanes-acetone 70:30, v:v) indicated completion of the reaction, which was quenched by the addition of solid NaHCO 3 . After addition of CH 2 Cl 2 , the mixture was filtered, washed with H 2 O, aqueous NaHCO 3 
N-(Benzyloxycarbonyl
A solution of disaccharide 7 (143 mg, 0.142 mmol) in a mixture of CH 3 CO 2 H (4 mL) and H 2 O (1 mL) was kept at 80°C for 1 h after which TLC analysis (hexanes-EtOAc 1:1, v:v) indicated completion of the reaction. The mixture was co-evaporated with toluene and the residue dried in vacuo. The recovered material was acetylated with pyridine (2 mL) and Ac 2 O (0.2 mL) in the presence of a catalytic amount of dimethylaminopyridine (DMAP) for 12 h. After the addition of CH 3 OH, the mixture was co-evaporated with toluene, the residue dissolved in CH 2 Cl 2 and washed with aqueous NaH-CO 3 CTP (126 mg, 0.239 mmol) was added to a solution of Neu5,9Ac 2 3 (50 mg, 0.142 mmol) in a Tris-HCl buffer (0.1 M, 9 mL, pH 7.5) containing DET (4.75 mM) and MnCl 2 (13.80 mM). Addition of CTP resulted in a change of pH from 7.5 to 6.5, which was re-adjusted to pH 7.5 using aqueous NaOH (0.3 M). The recombinant CMP-sialic acid synthetase from N. meningitis (9.2 U, 27.0 lL) and the inorganic pyrophosphatase from T. thermophilus (4.6 U, 60.0 lL) were added, and the reaction mixture was incubated at 37°C for 1 h with occasional shaking. Another portion of CMP-sialic acid synthetase and inorganic pyrophosphatase (1.5 U, 19.5 lL) was added after 2.5 h. The formation of a white precipitate (presumably manganese-ammonium phos-phate) was observed after 1.5 h. The progress of the reaction was monitored by TLC (EtOH-1 M NH 4 HCO 3 , 4:1, v:v), which after 5 h indicated completion of the reaction. Ethanol (80 mL) was added and the mixture was kept on ice for 2 h prior to centrifugation. The supernatant was decanted and the pellet (mostly inorganic salts) was re-suspended in EtOH (30 mL), cooled on ice for 1 h and centrifuged. The combined ethanol extracts were concentrated in vacuo providing crude material (230 mg). Ethanol (1.8 mL) was slowly added to the material dissolved in H 2 O (0.2 mL) and precipitation occurred immediately. The mixture was kept on ice for 2 h, and the supernatant was removed after centrifugation. After drying, NMR (D 2 O) of the first pellet (114 mg) indicated the presence of the expected product, some Tris, ethanol and a small amount of Neu5,9Ac 2 . The recovered material was again dissolved in H 2 O (0.2 mL) and re-precipitated by the addition of ethanol (1.80 mL) as described above providing 75 mg of material, which was loaded on a column of extra-fine Biogel P-2 (75 Â 1.5 cm) and eluted with 0.1 M NH 4 HCO 3 at 4°C. The appropriate fractions were detected by UV and TLC (as above), collected, concentrated in vacuo (bath temperature <25°C) and lyophilized from H 2 O (three times to completely remove NH 4 HCO 3 ) to afford 3 (60 mg, 61%, ammonium salt). Recombinant rat a-(2?3)-sialyltransferase from S. frugiperda [EC 2.4.99.4] (10 mU, 7 lL) and calf intestine alkaline phosphatase (15 U, 15 lL) were added to a mixture of disaccharide 10 (4.6 mg, 7.1 lmol) in cacodylate buffer (50 mM, pH 6.2; 600 lL) containing 0.1% Triton X-100, 0.1% BSA and CMP-Neu5,9Ac 2 4 (6.7 mg, 9.5 lmol) in an Eppendorf tube, and five similar reactions were run in parallel. The tubes were incubated at 37°C, and progress of the reactions were monitored by TLC (CHCl 3 -CH 3 OH-H 2 O-AcOH 60:40:10:0.5, v:v:v:v). After 2 h, an additional amount of a(2?3)-sial-yltransferase (10 mU), calf intestine alkaline phosphatase and CMP-Neu5,9Ac 2 (7.0 mg) was added to each of the five tubes. After 5.5 h, TLC indicated the disappearance of disaccharide 10. Each reaction was quenched by the addition of CH 3 OH (10 lL), combined and freeze dried to provide a crude material (200 mg), which was applied on a Biogel fine P-2 column (75 Â 1.5 cm, using H 2 O as eluent at 8 mL/h) at 4°C. The product was detected by TLC, and appropriate fractions were combined and freeze dried to provide 11 (37 mg). This material was passed through a short column of BioRad AG 50W-X8 (100-200 mesh, Na + ) resin at 4°C, and the appropriate fractions freeze dried. The recovered material was purified by C-18 silica gel (5 g) column chromatography using a gradient of CH 3 CN in H 2 O (95:5?90:10, v:v, at 4°C), which removed the 9-O-deacetylated trisaccharide (1.0 mg) from the product 11 (22.5 mg, 69%); ½a
